Thymus Plays Key Role in Healthy Aging

New studies reveal the thymus remains active and crucial even in adulthood, impacting overall health and disease risk.

Mar. 27, 2026 at 2:56am

Got story updates? Submit your updates here. ›

Recent studies led by researchers at Harvard University and partners have found that the thymus, a small organ in the upper chest that produces T cells, plays a central role in immune function and healthy aging, even in adulthood. The studies show that thymus health, as measured by CT scans, is an independent predictor of survival, disease risk, and success of cancer immunotherapies. A healthier thymus is linked to lower mortality, reduced cancer incidence, and better outcomes with immune checkpoint inhibitors.

Why it matters

These findings fundamentally change the perception of the thymus, from a 'childhood organ' with little relevance in adulthood to a key regulator of immune-mediated aging and disease susceptibility. As a biomarker, thymus health could improve early detection of at-risk patients, guide selection of immunotherapies, and optimize treatment timing. Strategies to strengthen or regenerate the thymus are becoming a focus of research, as thymus health may have a decisive impact on quality of life, life expectancy, and treatment success.

The details

The researchers developed a deep learning framework to quantify thymus health from routine CT scans. Analyzing over 27,000 scans from two major US studies, they found that good thymus health was associated with 50% lower overall mortality, 36% reduced lung cancer incidence, and 63-92% decreased cardiovascular mortality. A second study of over 3,400 cancer patients showed those with high thymus health had significantly better outcomes with immune checkpoint inhibitors, independent of other biomarkers. Thymus health reflects immune system performance, with greater T-cell receptor diversity and stronger immune response.

  • The studies were published in Nature in 2026.

The players

Harvard University

The university that led the international research studies on the role of the thymus in healthy aging and cancer immunotherapy outcomes.

Dr. Simon Bernatz

The first author of the publications and a physician and research associate at the Clinic for Radiology and Nuclear Medicine at Universitätsmedizin Frankfurt.

Professor Thomas Vogl

The Director of the Clinic for Radiology and Nuclear Medicine at Universitätsmedizin Frankfurt.

Got photos? Submit your photos here. ›

What they’re saying

“The publications in Nature underscore the extraordinary scientific and clinical relevance of this work. They impressively demonstrate the contribution modern imaging can make in revealing previously underestimated biological connections.”

— Professor Thomas Vogl, Director of the Clinic for Radiology and Nuclear Medicine at Universitätsmedizin Frankfurt

“Our analyses show for the first time that thymus health seems to be an independent predictor of survival and disease risks. Particularly noteworthy is that we were able to obtain this information from routine computer tomography (CT) scans.”

— Dr. Simon Bernatz, Physician and research associate at the Clinic for Radiology and Nuclear Medicine at Universitätsmedizin Frankfurt

What’s next

Researchers are now focusing on developing targeted strategies to strengthen or regenerate the thymus, as its health may have a significant impact on quality of life, life expectancy, and treatment success.

The takeaway

This research fundamentally changes the perception of the thymus, revealing it as a central regulator of immune-mediated aging and disease susceptibility in adulthood. Thymus health, as measured by routine CT scans, could become an important biomarker for early detection of at-risk patients, guiding personalized treatment approaches, and optimizing the timing of medical interventions.